News
ARAY
0.2621
+0.23%
0.0006
Accuray Shareholders Approve Financing and Reverse Stock Split
TipRanks · 19h ago
Accuray appoints Richard Meier to board of directors
TipRanks · 19h ago
Accuray stockholders approves transactions with TCW Asset Management Company
TipRanks · 19h ago
Press Release: Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
Dow Jones · 20h ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 1d ago
Weekly Report: what happened at ARAY last week (0928-1002)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 4d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 09/29 21:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 09/29 12:05
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 09/28 17:06
Why Is Accuray Stock Gaining Monday?
Benzinga · 09/28 12:09
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 09/28 12:05
Why is Accuray Incorporated Stock (ARAY) Up 60% Today?
TipRanks · 09/28 10:49
Weekly Report: what happened at ARAY last week (0921-0925)?
Weekly Report · 09/28 10:12
Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Benzinga · 09/28 09:29
Accuray, Samsung NeuroLogica Collaborate On Advanced Imaging For CyberKnife System
NASDAQ · 09/28 02:46
Accuray, Samsung NeuroLogica advance volumetric imaging collaboration
TipRanks · 09/27 15:25
Weekly Report: what happened at ARAY last week (0914-0918)?
Weekly Report · 09/21 10:12
Weekly Report: what happened at ARAY last week (0907-0911)?
Weekly Report · 09/14 10:17
Accuray Agrees To Acquire RayStation Licenses For $8M From RaySearch Laboratories
Benzinga · 09/11 15:35
More
Webull provides a variety of real-time ARAY stock news. You can receive the latest news about Accuray Incorp through multiple platforms. This information may help you make smarter investment decisions.
About ARAY
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.